Skip to main content
Log in

Leukotriene B4 and inflammatory disease

  • Immunosuppression and Inflammation
  • Editorial
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Polymorphonuclear leukocytes (PMNL) are prominent at sites of acute inflammation. Their infiltration is stimulated under pathological conditions by a variety of agents which include bacteria, immune complexes and complement derived chemotactic peptides. Recently attention was focussed on the 5-lipoxygenase product leukotriene B4 (LTB4) which has been demonstrated to induce the key features associated with an acute inflammatory reaction. However, evidence supporting a pro-inflammatory role for LTB4, and therefore the anti-inflammatory efficacy of 5-lipoxygenase inhibitors, is largely circumstantial. Moreover, there are concerns that other chemotactic factors, notably C5a, may compensate for the absence of LTB4. Here we challenge this view and, on the basis of recent experimental and clinical data suggest that LTB4 does not simply duplicate the activity of C5a. Instead we propose that their predominant site(s) of action differ in such a way that they may synergise in mediating PMNL recruitment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. A. W. Ford-Hutchinson, M. A. Bray, M. V. Doig, M. E. Shipley and M. J. H. Smith,Leukotriene B: a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature286, 264–265 (1980).

    PubMed  Google Scholar 

  2. T. E. Rollins, B. Zanolari, M. S. Springer, Y. Guindon, R. Zamboni, C.K. Lau and J. Rokach,Synthetic leukotriene B 4 is a potent chemotaxin but a weak secretagogue for human PMN. Prostaglandins25, 281–289 (1983).

    PubMed  Google Scholar 

  3. H. J. Showell, P. H. Naccache, P. Borgeat, S. Picard, P. Vallerand, E. L. Becker and R. I. Sha'afi,Characterization of the secretory activity of leukotriene B 4 toward rabbit neutrophils. J. Immunol.128, 811–816 (1982).

    PubMed  Google Scholar 

  4. J. Palmblad, C. L. Malmsten, A.-M. Uden, O. Radmark, L. Engstedt and B. Samuelsson,LTB 4 is a potent stereospecific stimulator of neutrophil chemotaxis and adherence. Blood58, 658–661 (1981).

    PubMed  Google Scholar 

  5. E. J. Geotzl and W. C. Picket,The human polymorphonuclear leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETE'S). J. Immunol.125, 1789–1791 (1980).

    PubMed  Google Scholar 

  6. R. A. Lewis, E. J. Goetzel, J. M. Drazen, N. A. Soter, K. F. Austen and E. J. Corey,Functional characterization of synthetic leukotriene B 4 and its stereochemical isomers. J. Exp. Med.154, 1243–1248, (1981).

    PubMed  Google Scholar 

  7. A. W. Ford-Hutchinson, A. Rackham, R. Zamboni, J. Rokach and S. Roy,Comparative biological activities of synthetic leukotriene B 4 and its w-oxidation products. Prostaglandins25, 29–37 (1983).

    PubMed  Google Scholar 

  8. R. A. Kreisle and C. W. Parker,Specific binding of leukotriene B 4 to a receptor on human polymorphonuclear leukocytes. J. Exp. Med.157, 628–641 (1983).

    PubMed  Google Scholar 

  9. D. W. Goldman and E. J. Goetzl,Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B 4 . J. Exp. Med.159, 1027–1041 (1984).

    PubMed  Google Scholar 

  10. D. W. Goldman, L. A. Gifford, D.M. Olson, and E. J. Goetzl,Transduction by leukotriene B 4 receptors of increases in cytosolic calcium in human polymorphonuclear leukocytes. J. Immunol.135, 525–530 (1985).

    PubMed  Google Scholar 

  11. D. W. Goldman, L. A. Gifford, T. Marotti, C. H. Koo and E. J. Goetzl,Molecular and cellular properties of human polymorphonuclear leukocyte receptors for leukotriene B 4 . Federation Proc.46, 200–203 (1987).

    Google Scholar 

  12. R. Synderman and E. J. Goetzl,Molecular and cellular mechanisms of leukocyte chemotaxis. Science213, 830–837 (1981).

    PubMed  Google Scholar 

  13. P. Bhattacherjee, K. E. Eakins and B. Hammond,Chemotactic activity of arachidionic acid and lipoxygenase products in the rabbit eye. Br. J. Pharmac.73. 254P (1981).

  14. M. A. Bray, A. W., Ford-Hutchinson and M. J. H. Smith,Leukotriene B 4 :an inflammatory mediator in vivo. Prostaglandins22, 213–222 (1981).

    PubMed  Google Scholar 

  15. N. C. Staub, E. L. Schultz, K. Koike and K. H. Albertine.Effect of neutrophil migration induced by leukotriene B 4 on protein permeability in sheep lung. Fedn. Proc.44, 30–35 (1985).

    Google Scholar 

  16. M. J. H. Smith, A. W. Ford-Hutchinson and M. A. Bray,Leukotriene B: a potential mediator of inflammation. J. Pharm. Pharac.32, 517–518 (1980).

    Google Scholar 

  17. N. A. Soter, R. A. Lewis, E. J. Corey, and K. F. Austen,Local effects of synthetic leukotrienes (LTC 4 ,LTD 4 LTE 4 and LTB 4 )in human skin. J. Invest. Dermatol.80, 115–119 (1983).

    PubMed  Google Scholar 

  18. R. Camp, R. R. Jones, S. Brain, P. Woolard and M. Greaves,Production of intraepidermal microabscesses by topical application of leukotriene B 4 J. Invest. Dermatol.84, 427–429 (1985).

    PubMed  Google Scholar 

  19. C. V. Wedmore and T. J. Williams,Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature289, 646–650 (1981).

    PubMed  Google Scholar 

  20. M. J. Forrest, P. J. Jose and T. J. Williams,Kinetics of the generation and action of chemical mediators in zymosan-induced inflammation of the rabbit peritoneal cavity. Br. J. Pharmac.89, 719–730 (1986).

    Google Scholar 

  21. L. Lindbom, P. Hedqvist, S.-E. Dahlen, J. A. Lindgren and K.-E. Arfors,Leukotriene B 4 induces extravasation and migration of polymorphonuclear leukocytes in vivo. Acta. Physiol. Scand.116, 105–108 (1982).

    PubMed  Google Scholar 

  22. R. M. J. Palmer and J. A. Salmon,Release of leukotriene B 4 from human neutrophils and its relationship to degranulation induced by N-formylmethionyl-leucyl-phenylalanine, serumtreated zymosan, and the ionophore A23187. Immunology50, 65–73 (1983).

    PubMed  Google Scholar 

  23. P. A. J. Henricks, M. E. Van der Tol, F. Engels, F. P. Nijkamp and J. Verhoef,Human polymorphonuclear leukocytes release leukotriene B 4 during phagocytosis of Staphylococcus aureus. Inflammation10, 37–47 (1986).

    PubMed  Google Scholar 

  24. R. M. Clancy, C. A. Dahinden and T. E. Hugli,Arachidonate metabolism by human polymorphonuclear leukocytes stimulated with N-formyl-met-leu-phe or complement component C 5 a is independent of phospholipase activation. Proc. Nat. Acad. Sci. U.S.A.80, 7200–7204 (1983).

    Google Scholar 

  25. J. O. Williams, T. H. Lee, R. A. Lewis and F. Austen,Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B 4 ,by human neutrophils activated with unopsonised zymosan. J. Immunol.134, 2624–2630 (1985).

    PubMed  Google Scholar 

  26. W. Seeger, N. Suttorp, A. Hellwig and S. Bhadki,Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B 4 generation in human polymorphonuclear leukocytes. J. Immunol.137, 1286–1293 (1986).

    PubMed  Google Scholar 

  27. J. D. Williams, J. K. Czop and K. F. Austen,Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators. J. Immunol.132, 3034–3040 (1984).

    PubMed  Google Scholar 

  28. M. E. Goldyne, G. F. Burrish, P. Poubelle and P. Borgeat,Arachidonic acid metabolism among human mononuclear leukocytes: lipoxygenase related pathways. J. Biol.-Chem.259, 8815–8819 (1984).

    PubMed  Google Scholar 

  29. R. J. Bonney, E. E. Opas and J. L. Humes,Lipoxygenase pathways of macrophages. Fed. Proc.44, 2933–2936 (1985).

    PubMed  Google Scholar 

  30. P. M. Simmons, J. A. Salmon and S. Moncada,The release of leukotriene B 4 during experimental inflammation. Biochem. Pharmac.32, 1353–1359 (1983).

    Google Scholar 

  31. D. M. Aked and S. J. Foster,Leukotriene B 4 and acute inflammation in the rabbit. Br. J. Pharmac.90, 235P (1987).

  32. A. D. Sedgwick and P. Lees,Studies of eicosanoid production in the air pouch model of synovial inflammation. Agents and Actions18, 429–438 (1986).

    PubMed  Google Scholar 

  33. S. J. Foster, M. E. McCormick, A. Howarth and D. Aked,Leukocyte recruitment in the subcutaneous sponge implant model of acute inflammation in the rat is not mediated by leukotriene B 4 Biochem. Pharmac.35, 1709–1717 (1986).

    Google Scholar 

  34. D. E. Kopp, B. Esser, T. Tashoff, D. W. Goldman, E. J. Goetzl and R. F. Lemanske,In vivo and in vitro assessment of the role of leukotriene B 4 as a mediator of rat cutaneous late-phase reactions. J. Allergy and Clin. Immunol.77, 302–308 (1986).

    Google Scholar 

  35. R.A. Kreisle, C. W. Parker, G. L. Griffin, R. M. Senior and W. F. Stenson,Studies of leukotriene B 4 -specific binding and function in rat polymorphonuclear leukocytes: absence of a chemotactic response. J. Immunol.134, 3356–3363 (1985).

    PubMed  Google Scholar 

  36. G. A. Higgs, J. A. Salmon and J. A. Spayne,The inflammatory effects of hydroperoxy and hydroxy acid products of arachidonate lipoxygenase in rabbit skin. Br. J. Pharmac.74 429–433 (1981).

    Google Scholar 

  37. H. Z. Movat, C. Rettl, C. E. Burrowes, and M. G. Johnston,The in vivo effect of leukotriene B 4 on polymorphonuclear leukocytes and the microcirculation. Am. J. Pathol.115, 233–244 (1984).

    PubMed  Google Scholar 

  38. D. Aked, S. J. Foster, A. Howarth, M. E. McCormic and H. C. Potts,The inflammatory response of rabbit skin to topical arachidonic acid and its pharmacological modulation. Br. J. Pharmac.89, 431–438 (1986).

    Google Scholar 

  39. D. M. Aked and S. J. Foster,The contribution of eicosanoids to the acute inflammatory reaction induced by arachidonic acid in rabbit skin. Br. J. Pharmac.90, 58P (1987).

  40. D. M. Aked and S. J. Foster,Leukotriene B 4 and prostaglandin E 2 mediate the inflammatory response of rabbit skin to intradermal arachidonic acid. Br. J. Pharmac.92, 545–552 (1987).

    Google Scholar 

  41. S. A. Raé, E. M. Davidson and M. J. H. Smith,Leukotriene B 4 ,an inflammatory mediator in gout. Lancetii, 1122–1124 (1982).

    Google Scholar 

  42. R. M. McMillan, S. J. Foster and P. A. Dieppe,Leukotriene B 4 metabolism in human leukocytes: fact or artefact? Agents and Actions21, 1–3 (1987).

    Google Scholar 

  43. S. Shak and I. M. Goldstein,w-oxidation is the major pathway for the catabolism of leukotriene B 4 in human polymorphonuclear leukocytes. J. Biol. Chem.259, 10181–10187 (1984).

    PubMed  Google Scholar 

  44. P. A. Simkin and K.-L. Nilson,Trans-synovial exchange of large and small molecules. In:clinics in rheumatic diseases, Vol. 7. The biology of the joint, pp. 99–129 (Ed. P. Hasselbacher), W. B. Saunders Co. Ltd., London (1981).

    Google Scholar 

  45. M. G. Tonnesen, L. Smedly, A. Goins and P. M. Henson,Interaction between neutrophils and vascular endothelial cells. In: Agents and Actions, Suppl., Cologne Atherosclerosis Conference XI, pp. 25–38 (Eds. M. J. Parnham and J. Winkelmann) Birkhäuser Verlag, Basel (1982).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

McMillan, R.M., Foster, S.J. Leukotriene B4 and inflammatory disease. Agents and Actions 24, 114–119 (1988). https://doi.org/10.1007/BF01968088

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01968088

Navigation